Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Fernandez

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Diseases of the Colon and Rectum|May 9, 2020
Metformin Use in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation: The New Magic Bullet?Rodrigo Oliva Perez, Laura M Fernandez, Cinthia D Ortega
Surgical Endoscopy|August 19, 2018
How accurate is preoperative colonoscopic localization of colonic neoplasia?Laura M Fernandez, Rowaa N M Ibrahim, Ido Mizrahi, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 26, 2021
Elective minimally invasive surgery for sigmoid diverticulitis: operative outcomes of patients with complicated versus uncomplicated diseaseIdo Mizrahi, Mahmoud Abu-Gazala, Laura M Fernandez, et al.
Diseases of the Colon and Rectum|January 23, 2025
Do We Really Know That a "Substantial" Proportion of Near-Complete Pathological Responses Become Complete Over Time?Guilherme P São Julião, Laura M Fernandez, Bruna B Vailati, et al.
Diseases of the Colon and Rectum|September 8, 2018
Lateral Node Dissection in Rectal Cancer in the Era of Minimally Invasive Surgery: A Step-by-Step Description for the Surgeon Unacquainted with This Complex Procedure with the Use of the Laparoscopic ApproachRodrigo Oliva Perez, Guilherme P São Julião, Bruna Borba Vailati, et al.
Frontiers in Oncology|October 17, 2022
Zebrafish Avatars of rectal cancer patients validate the radiosensitive effect of metforminBruna Costa, Laura M Fernandez, Oriol Parés, et al.
Discover Oncology|July 6, 2026
Clinical and biological implications of fragmented response in rectal cancer after neoadjuvant chemoradiotherapyJosé M Azevedo, Diogo Relveiro, Matilde Gama, et al.
Diseases of the Colon and Rectum|October 24, 2025
A Significant Proportion of Stage II and III Rectal Cancers, Selected by Precision Magnetic Resonance, Can Safely Be Managed by Upfront Total Mesorectal Excision Surgery Without Neoadjuvant TherapyLaura M Fernandez, José Moreira Azevedo, Ines Santiago, et al.
Diseases of the Colon and Rectum|August 10, 2016
Should We Give Up The Search for a Clinically Useful Gene Signature for the Prediction of Response of Rectal Cancer to Neoadjuvant Chemoradiation?Rodrigo O Perez, Angelita Habr-Gama, Guilherme P São Julião, et al.
Annals of Surgery|April 5, 2019
Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over TimeGuilherme P São Julião, Georgios Karagkounis, Laura M Fernandez, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Diseases of the Colon and Rectum|May 9, 2020
Metformin Use in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation: The New Magic Bullet?Rodrigo Oliva Perez, Laura M Fernandez, Cinthia D Ortega
Surgical Endoscopy|August 19, 2018
How accurate is preoperative colonoscopic localization of colonic neoplasia?Laura M Fernandez, Rowaa N M Ibrahim, Ido Mizrahi, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 26, 2021
Elective minimally invasive surgery for sigmoid diverticulitis: operative outcomes of patients with complicated versus uncomplicated diseaseIdo Mizrahi, Mahmoud Abu-Gazala, Laura M Fernandez, et al.
Diseases of the Colon and Rectum|January 23, 2025
Do We Really Know That a "Substantial" Proportion of Near-Complete Pathological Responses Become Complete Over Time?Guilherme P São Julião, Laura M Fernandez, Bruna B Vailati, et al.
Diseases of the Colon and Rectum|September 8, 2018
Lateral Node Dissection in Rectal Cancer in the Era of Minimally Invasive Surgery: A Step-by-Step Description for the Surgeon Unacquainted with This Complex Procedure with the Use of the Laparoscopic ApproachRodrigo Oliva Perez, Guilherme P São Julião, Bruna Borba Vailati, et al.
Frontiers in Oncology|October 17, 2022
Zebrafish Avatars of rectal cancer patients validate the radiosensitive effect of metforminBruna Costa, Laura M Fernandez, Oriol Parés, et al.
Discover Oncology|July 6, 2026
Clinical and biological implications of fragmented response in rectal cancer after neoadjuvant chemoradiotherapyJosé M Azevedo, Diogo Relveiro, Matilde Gama, et al.
Diseases of the Colon and Rectum|October 24, 2025
A Significant Proportion of Stage II and III Rectal Cancers, Selected by Precision Magnetic Resonance, Can Safely Be Managed by Upfront Total Mesorectal Excision Surgery Without Neoadjuvant TherapyLaura M Fernandez, José Moreira Azevedo, Ines Santiago, et al.
Diseases of the Colon and Rectum|August 10, 2016
Should We Give Up The Search for a Clinically Useful Gene Signature for the Prediction of Response of Rectal Cancer to Neoadjuvant Chemoradiation?Rodrigo O Perez, Angelita Habr-Gama, Guilherme P São Julião, et al.
Annals of Surgery|April 5, 2019
Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over TimeGuilherme P São Julião, Georgios Karagkounis, Laura M Fernandez, et al.
Pageof 4